Bloomberg - Oct. 18 (Bloomberg) -- Pfizer Inc., the world's largest drugmaker, said third-quarter profit fell 77 percent on costs for discontinuing the diabetes treatment Exubera and on competition from cheaper copies of its best-selling drugs. Pfizer abandoned ...
